XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
JAKARTA,Indonesia,Feb. 13,2025-- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) continues to demonstrate resilience amid economic challenges,recording a consolidated net profit of IDR 60.64 trilli
PUNE,India,Feb. 13,2025-- enreapis proud to be Certified™ by Great Place To Work® for the third year in a row. The prestigious award is based entirely on what current employees say about their ex
TOKYO,Feb. 13,2025-- Applibot,Inc. (Headquarters: Shibuya,Tokyo; President: Koki Ukita) is launching a smartphone app "Chiikawa Pocket," in 43 countries and regions worldwide in late March 2
HONG KONG,Feb. 14,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China Natio
As a reminder,Aquarius\' innovative systems generate and supply clean electricity,designed to enable ultra-fast charging for electric vehicles in the rapidly growing EV market. Aquarius\' systems are
